Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.65
0.231.4%
Ult. Agg.: Oct 22, 3:28 PM
$16.42
N/A
Market sentiment signals for Aktis Oncology (AKTS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$32
+89.2%
Highest Price Target
$40
+140.2%
Lowest Price Target
$1
-94.0%
Short Interest
29.2%
Rising — Bearish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Wedbush | David Nierengarten— | +110.2% | $35 → $35 | Maintained | Outperform |
| Sep 9, 2026 | Oppenheimer | Jeff Jones— | +140.2% | $40 | Initiate | Outperform |
